Location History:
- Mions, FR (2001)
- Moins, FR (2001)
Company Filing History:
Years Active: 2001
Title: Innovations by Philippe Barthelemy
Introduction
Philippe Barthelemy is a notable inventor based in Mions, France. He has made significant contributions to the field of pharmaceutical compositions, holding 2 patents that showcase his innovative approach to drug delivery systems.
Latest Patents
His latest patents include a "Composition with sustained release of active principle, capable of forming a microemulsion." This invention involves a composition that comprises a microemulsion forming system activated by contact with a hydrophilic phase after ingestion. The system includes an active principle, a lipophilic phase, a surfactant, and a co-surfactant. Notably, it also features an inert polymeric matrix that forms a gelled structure upon contact with physiological fluids, allowing for the continuous and prolonged release of the micro-emulsified active principle.
Another significant patent is the "Method for preparing a pharmaceutical composition with modified release of the active principle, comprising a matrix." This method outlines a process for creating a modified release of an active principle by mixing powders and coating them with a lipid matrix agent. The innovative approach ensures that the active ingredients are effectively delivered in a controlled manner.
Career Highlights
Philippe Barthelemy is associated with Gattefosse S.A., a company known for its expertise in pharmaceutical and cosmetic formulations. His work at Gattefosse has allowed him to develop cutting-edge solutions that enhance drug delivery and efficacy.
Collaborations
He has collaborated with notable colleagues such as Nabil Farah and Joseph Joachim, contributing to the advancement of pharmaceutical technologies.
Conclusion
Philippe Barthelemy's innovative work in the field of pharmaceutical compositions demonstrates his commitment to improving drug delivery systems. His patents reflect a deep understanding of the complexities involved in creating effective and sustained-release formulations.